Research Ultragenyx, after FDA speed bump, lands 1st gene therapy nod with green light in glycogen storage diseaseBy Healthcare Propulsion StaffAugust 20, 20260 If at first you don’t succeed in gene therapy, then try, try again. That’s the lesson Ultragenyx likely took home…
Research BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nodBy Healthcare Propulsion StaffAugust 14, 20260 In a historic breakthrough for targeted protein degradation, Bristol Myers Squibb has secured the first FDA approval for a CELMoD…
